APA (7th ed.) Citation

Mohammed, H. E., Gomaa, M. A., Khalifa, Y. M., & Shawky, A. A. (2025). Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials. BMC Psychiatry, 25(1), 1. https://doi.org/10.1186/s12888-025-06696-5

Chicago Style (17th ed.) Citation

Mohammed, Hazem E., Menna A. Gomaa, Youssef Magdy Khalifa, and Ahmed Ayman Shawky. "Does KarXT (xanomeline-trospium) Represent a Novel Approach to Schizophrenia Management? A GRADE-assessed Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials." BMC Psychiatry 25, no. 1 (2025): 1. https://doi.org/10.1186/s12888-025-06696-5.

MLA (9th ed.) Citation

Mohammed, Hazem E., et al. "Does KarXT (xanomeline-trospium) Represent a Novel Approach to Schizophrenia Management? A GRADE-assessed Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials." BMC Psychiatry, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12888-025-06696-5.